Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
New England Journal of Medicine, 373(1), 4859
GLP-1: MICRODOSE VS
In the current study which did not undergo peer review the researchers assessed the likelihood of a dementia diagnosis within 5 years of starting a GLP-1 receptor agonist or another diabetes medication using a cohort of 549,822 patients aged 60 years or older with type 2 diabetes
Readers seeking additional category context may also find value in this related industry analysis of weight loss patches and GLP-1 alternatives published earlier this month
This suggests as many as one in 1,000 GLP-1 RA users could progress to new age-related macular degenaration over unexposed patients: if this risk was carried over millions of users, those affected could end up being a sizable group of patients, he said
US$ 29.06
US$ 21.87
US$ 28.45
